Dosage for bronchospasm caused by certain lung diseases Doctors may prescribe albuterol inhaler to treat and help prevent bronchospasm caused by certain lung diseases, such as asthma and COPD.

Increasing Prevalence of Asthma and COPD: The rising incidence of asthma and chronic obstructive pulmonary disease (COPD) ...

A first-in-class, pressurised metered-dose inhaler (pMDI), fixed-dose combination rescue medication containing albuterol ... asthma and chronic obstructive pulmonary disease (COPD) in the US ...

One red inhaler contains the rescue medication albuterol. Another red inhaler is a combination ... Rogliani P, Calzetta L, Coppola A, et al. Optimizing drug delivery in COPD: the role of inhaler ...

In January 2023, the Food and Drug Administration (FDA) approved Airsupra (albuterol and budesonide ... Quantitative characterization of circadian rhythm of pulmonary function in asthmatic patients ...

Objectives Continuous albuterol nebulization is generally administered at 2.5–20 mg/hr at most centers. We examined the effect of high-dose (75 or 150 mg/hr) albuterol on clinical variables in ...

each patient was randomized to receive at least two consecutive doses of albuterol 2.5 mg or levalbuterol 1.25 mg four hours apart via nebulization. HR was recorded at the end of the second dose ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...